Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center Study of the Effect of Sevelamer Carbonate (Renvela®) on Metabolic/Inflammatory/ROS in Diabetics With Nephropathy

NCT01493050 is registered in ClinicalTrials.gov with Gary Striker as lead sponsor.

NCT NCT01493050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01493050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center Study of the Effect of Sevelamer Carbonate (Renvela®) on Metabolic/Inflammatory/ROS in Diabetics With Nephropathy
Lead sponsor
Gary Striker
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2012
Completion date
December 31, 2013
Enrollment
117 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathy